![Sciensus nurse and man at table](https://www.sciensus.com/wp-content/uploads/2023/10/MicrosoftTeams-image-4.jpg)
Our approach.
Our expertise drives greater patient engagement. Guided by more than 70 million powerful patient interactions, we uncover invaluable real-world insight to help pharmaceutical companies and clinicians drive greater patient engagement and improve medical adherence.
Greater patient engagement leads to better health outcomes
Engaging and empowering patients to become more active participants in their health journey is key to ensuring they can get the most out of their medication and overall treatment. Patients who are actively involved in managing their condition make healthier choices, ask for advice when they need it, take their medication as prescribed and – crucially – achieve better outcomes. Powered by advanced patient apps, digital health platforms and in-person support, we collect meaningful insights from patients about how they interact with their medicines in the real world. Armed with this insight, we develop and deliver innovative patient support programmes and help clinicians and pharmaceutical companies to drive better outcomes for patients.
Expertise informed by evidence
Explore our collection of white papers and case studies to discover how we gather, evaluate, and harness real-world patient-reported data to tackle healthcare challenges and improve patient outcomes.
![Woman on swing](https://www.sciensus.com/wp-content/uploads/2023/10/7a9e325e-8893-462c-a6b7-8e8bceb3f59f-image-contentblock-08.png)
Blog
Early access programs – benefits, challenges and the Sciensus solution
You have a novel therapy making significant progress in clinical trials and are already receiving requests for access from various…
![Early access programs](https://www.sciensus.com/wp-content/uploads/2023/10/MicrosoftTeams-image-26-640x720.jpg)
Thought Leadership
Enabling early access to rare and orphan drugs in Europe
![launching an orphan drug in europe](https://www.sciensus.com/wp-content/uploads/2023/10/launching-orphan-drug-in-europe-case-study-640x404.jpg)
Case Studies
How Sciensus supported the launch of a breakthrough therapy in Europe and beyond
Overview Sciensus has more than 30 years’ experience supporting pharmaceutical companies with the launch and distribution of orphan drugs outside…